Liver Injury After COVID-19 Vaccination

Humanity & Health Medical Group Limited

Status: Enrolling

Conditions: Subjects After COVID-19 Vaccination

Treatments: Biological: Approved COVID-19 vaccine

Study type: Observational

Funder types: Other

Identifiers

NCT05470894

APCOVLI-2022-01

Details and patient eligibility

About

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is still raging across the world and vaccination is expected to lead us out of this pandemic. Although the efficacy of these vaccines is beyond doubt, safety still remains a concern. Liver injury, such as autoimmune hepatitis (AIH), has been reported after COVID-19 vaccination. The aim of this prospective study is to investigate the spectrum and profile of liver injury after COVID-19 vaccination in Asia-Pacific region and to explore the potential risk factors for the development of liver injury.

Enrollment: 5,000 estimated patients

Sex: All

Ages: 5+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Subjects who have received at least one dose of approved COVID-19 vaccine;
• Volunteer to participate in this study.

Exclusion criteria

• No valid consent.

Trial design

5,000 participants in 1 patient group

COVID-19 Vaccination Group

Description:

Subjects who have received at lease one dose of approved COVID-19 vaccine

Treatment:

Biological: Approved COVID-19 vaccine